CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
Intest Res. 2019;17(3):349-356.   Published online February 8, 2019
DOI: https://doi.org/10.5217/ir.2018.00064

Excel Download

Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
Intestinal Research. 2019;17(3):349-356   Crossref logo
Link1 Link2 Link3

Sa1732 - The Effects and Adherence of Asacol ® Comparing 2.4G Once Daily with 800Mg Three Times or 1200Mg Twice Daily for Maintain Therapy in the Ulcerative Colitis: Prospective Multicenter Randomized Study
Gastroenterology. 2018;154(6):S-373   Crossref logo
Link1 Link2

Assessment of Adherence to Mesalazine Maintenance Therapy Over One Year Using Mems® Monitoring System: A Substudy of the CODA trial Comparing Once Versus Three Times Daily Asacol® in Ulcerative Colitis (UC)
Gastroenterology. 2011;140(5):S-264   Crossref logo
Link1 Link2

T1136 Once-Daily MMX® 5-Aminosalicylic Acid Versus Twice-Daily Asacol® for the Maintenance of Remission of Ulcerative Colitis: A Preliminary Analysis
Gastroenterology. 2008;134(4):A-491   Crossref logo
Link1 Link2

A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis
Clinical Gastroenterology and Hepatology. 2003;1(3):170-173   Crossref logo
Link1 Link2

T1151 Once-Daily MMX® 5-Aminosalicylic Acid (2.4g/Day) Has a Similar Safety Profile to Twice-Daily Asacol® Delayed-Release Tablets (2.4g/Day): Results of a Superiority Trial for the Maintenance of Remission of Ulcerative Colitis
Gastroenterology. 2008;134(4):A-495   Crossref logo
Link1 Link2

83 Efficacy and Tolerability of a Once Daily Treatment with Budesonide Capsules Versus Mesalamine Granules for the Treatment of Active Ulcerative Colitis: A Randomized, Double-Blind, Double-Dummy, Multicenter Study
Gastroenterology. 2009;136(5):A-15   Crossref logo
Link1 Link2

Effectiveness of once-daily dosing with mesalamine for maintenance therapy in ulcerative colitis
Nature Reviews Gastroenterology & Hepatology. 2011;8(11):602-602   Crossref logo
Link1 Link2 Link3

Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine
Drug Design, Development and Therapy. 2011;111   Crossref logo
Link1

Tu1305 - High Effectiveness of Once Daily Dosing Regimen of 14-Day Rabeprazole-Levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Chronic Gastritis: A Prospective Randomized Study (The Once Study)
Gastroenterology. 2018;154(6):S-928-S-929   Crossref logo
Link1 Link2